J2151
J2151 – Inj, mannitol, 250 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 11 NDCs crosswalked per 250 MG $0.071/unit ASP+6%
📋 J2151 summary
J2151 is a HCPCS Level II J-code used to bill mannitol, 250 mg, billed per 250 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J2151: Mannitol(J2151), Osmitrol
Code J2151
Billing unit 250 MG Payment limit $0.071/unit NDC-Crosswalk 11
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ2151
DescriptorInj, mannitol, 250 mg
Billing unit250 MG
Payment limit / unit$0.071
Est. ASP / unit$0.067 est.
Mapped NDCs11
Data periodQ3 2026
Last updated2026-08-20
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$0.071
Est. ASP / unit
$0.067 est.
Est. after 2% sequester
$0.070
HCPCS dosage
250 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J2151 = 250 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J2151 WITH EST. MEDICARE PAY
11 NDCs map to J2151. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($0.071/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00404-9905-50 | Mannitol 12.5 g/50mL INJECTION, SOLUTION | Henry | 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9905-50... | 12.5 g/50mL | 50 | $3.55 | — | ● Active | CMS ASP |
| 00409-4031-01 | Mannitol 12.5 g/50mL INJECTION, SOLUTION | Hospira, | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4031-... | 12.5 g/50mL | 1,250 | $88.75 | — | ● Active | CMS + PDAC |
| 00990-7715-02 | Mannitol 20 g/100mL INJECTION, SOLUTION | ICU | 24 POUCH in 1 CASE (0990-7715-02) / 1 BAG... | 20 g/100mL | 4,800 | $340.80 | — | ● Active | CMS + PDAC |
| 00990-7715-03 | Mannitol 20 g/100mL INJECTION, SOLUTION | ICU | 12 POUCH in 1 CASE (0990-7715-03) / 1 BAG... | 20 g/100mL | 4,800 | $340.80 | — | ● Active | CMS + PDAC |
| 51662-1468-01 | MANNITOL 12.5 g/50mL INJECTION, SOLUTION | HF | 50 mL in 1 VIAL, SINGLE-DOSE (51662-1468-1... | 12.5 g/50mL | 50 | $3.55 | — | ● Active | CMS ASP |
| 51662-1468-03 | MANNITOL 12.5 g/50mL INJECTION, SOLUTION | HF | 25 POUCH in 1 CASE (51662-1468-3) / 1 VIA... | 12.5 g/50mL | 1,250 | $88.75 | — | ● Active | CMS ASP |
| 63323-0024-25 | Mannitol 250 mg/mL INJECTION, SOLUTION | Fresenius | 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-024-... | 250 mg/mL | 50 | $3.55 | — | ● Active | CMS + PDAC |
| 00264-7578-10 | Mannitol 20 g/100mL INJECTION, SOLUTION | B. | 24 CONTAINER in 1 CASE (0264-7578-10) / 5... | 20 g/100mL | 0.8 | $0.06 | — | ● Active | PDAC |
| 00338-0353-03 | Osmitrol Mannitol 10 g/100mL INJECTION, SOLUTION | Baxter | 500 mL in 1 BAG (0338-0353-03) | 10 g/100mL | 0.4 | $0.03 | — | ● Active | PDAC |
| 00338-0357-02 | Osmitrol Mannitol 20 g/100mL INJECTION, SOLUTION | Baxter | 250 mL in 1 BAG (0338-0357-02) | 20 g/100mL | 0.8 | $0.06 | — | ● Active | PDAC |
| 00338-0357-03 | Osmitrol Mannitol 20 g/100mL INJECTION, SOLUTION | Baxter | 500 mL in 1 BAG (0338-0357-03) | 20 g/100mL | 0.8 | $0.06 | — | ● Active | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$2.8K
Claims
925
Beneficiaries
281
Spend / beneficiary
$9.98
Spend / claim
$3.03
Trend by period
Where J2151 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #734 of 824
#729
HALDOL DECANOATE 100... J1631
$3.1K
#730
GEMCITABINE HCL(J919... J9196
$3K
#731
PAMIDRONATE DISODIUM J2430
$3K
#732
LEVOFLOXACIN-D5W J1956
$2.9K
#733
CLEOCIN PHOSPHATE* J0736
$2.8K
#734
MANNITOL(J2151) J2151
$2.8K
#735
CHLOROTHIAZIDE SODIU... J1205
$2.7K
#736
AZMIRO J1072
$2.7K
#737
DIPYRIDAMOLE J1245
$2.6K
#738
PROCHLORPERAZINE EDI... J0780
$2.5K
#739
PREDNISOLONE SODIUM... J7510
$2.4K
Total claims — #381 of 824
#376
POTELIGEO J9204
976
#377
LANREOTIDE ACETATE(J... J1932
970
#378
APRETUDE J0739
959
#379
OASIS ULTRA Q4124
939
#380
BLINCYTO J9039
933
#381
MANNITOL(J2151) J2151
925
#382
BEOVU J0179
920
#383
CABENUVA J0741
920
#384
ORPHENADRINE CITRATE J2360
916
#385
PEMRYDI RTU J9324
903
#386
ENJAYMO J1302
892
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $2.8K | 281 | 925 | $9.98 | $3.03 |
| 2025 (Q1-Q4) | $2.2K | 258 | 894 | $8.41 | $2.43 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$2.2K
Medicare paid
$1.7K
Submitted services
39,475
Denial rate
7.4%
Allowed / service
$0.06
Submitted charges
$135.8K
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
📊 What bills under J2151
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Not available in current dataset
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
11 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J2151 billing FAQ
What is HCPCS code J2151?
J2151 is a HCPCS Level II J-code used to bill Inj, mannitol, 250 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J2151?
One unit of J2151 represents 250 MG. Report the number of units equal to the dose administered divided by 250 MG.
How many units of J2151 should I bill?
Divide the dose administered by the code's unit size (250 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J2151?
The Medicare Part B payment limit is $0.071 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $0.070 per unit. Payment limits are revised quarterly.
Which NDCs bill under J2151?
11 NDCs currently map to J2151 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J2151 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.